ClinicalTrials.Veeva

Menu

Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse

Virginia Polytechnic Institute and State University logo

Virginia Polytechnic Institute and State University

Status

Active, not recruiting

Conditions

Alcohol Use Disorder

Treatments

Other: Online survey

Study type

Observational

Funder types

Other

Identifiers

NCT04788004
IQRR- Longitudinal Study

Details and patient eligibility

About

The goals of this study are to provide a scientific understanding of recovery and relapse, as well as to identify novel targets for future relapse prevention interventions.

Full description

The study will characterize long-term trajectories of recovery from alcohol use including the associated changes in psychosocial functioning and relapse status. By using an accelerated longitudinal design, competing neurobehavioral decision systems (CNDS) functioning (measured using delay discounting), psychosocial functioning, and relapse will be characterized over a 12-year period for individuals in alcohol use disorder (AUD) recovery.

Enrollment

733 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. be ≥18 yrs old
  2. meet lifetime DSM-5 AUD criteria
  3. have a Recovery Initiation Date less than 10 years prior to the time of enrollment
  4. be able to read independently
  5. be free of legal problems that could limit participation
  6. reside in the U.S.
  7. anticipate continued Internet access (to ensure ongoing contact and data collection)
  8. be a registrant of the International Quit and Recovery Registry (IQRR)

Exclusion criteria

  • Minors will not be included
  • Prisoners will not be included. If participants become incarcerated during this study, they will not be contacted to complete assessments during their incarceration. If the incarcerations ends during the study, they may be contacted to participate in assessments.
  • Adults who are not capable of consenting on their own behalf

Trial design

733 participants in 10 patient groups

Cohort 1
Description:
Participants in this group started their recovery process \< 1 year ago
Treatment:
Other: Online survey
Cohort 2
Description:
Participants in this group started their recovery process 1 to \<2 years ago
Treatment:
Other: Online survey
Cohort 3
Description:
Participants in this group started their recovery process 2 to \<3 years ago
Treatment:
Other: Online survey
Cohort 4
Description:
Participants in this group started their recovery process 3 to \<4 years ago
Treatment:
Other: Online survey
Cohort 5
Description:
Participants in this group started their recovery process 4 to \<5 years ago
Treatment:
Other: Online survey
Cohort 6
Description:
Participants in this group started their recovery process 5 to \<6 years ago
Treatment:
Other: Online survey
Cohort 7
Description:
Participants in this group started their recovery process 6 to \<7 years ago
Treatment:
Other: Online survey
Cohort 8
Description:
Participants in this group started their recovery process 7 to \<8 years ago
Treatment:
Other: Online survey
Cohort 9
Description:
Participants in this group started their recovery process 8 to \<9 years ago
Treatment:
Other: Online survey
Cohort 10
Description:
Participants in this group started their recovery process 9 to \<10 years ago
Treatment:
Other: Online survey

Trial contacts and locations

1

Loading...

Central trial contact

Kirstin M. Gatchalian; Warren K. Bickel, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems